Biogazelle
Universiteit Gent

Biogazelle

Biotech
Biotech
Biotech
Biotech

Acquired by CellCarta.

Biogazelle is a Ghent University spin-off founded in 2007 by Jo Vandesompele and Jan Hellemans from the Center for Medical Genetics. Since 2010, Biogazelle offers expert laboratory services in the area of gene expression analysis. To this purpose, several state-of-the-art laboratory methods such as RNA sequencing and digital PCR are being used, complemented with custom developed unique software tools, including qbase+.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
Flindr Therapeutics
Qbic III
HealthTech
HealthTech
HealthTech
HealthTech

Flindr Therapeutics

Flindr aims to restore a patient’s impaired immune response to cancer

Universiteit Gent
QustomDot
Qbic II
Deeptech
Deeptech
Deeptech
Deeptech

QustomDot

QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.

Universiteit Gent
EyeD Pharma
Qbic II
HealthTech
HealthTech
HealthTech
HealthTech

EyeD Pharma

EyeD Pharma is developing micro-implants for drug release over a prolonged period of time.

ULiège